PT-141 — Research Overview

Also known as: Bremelanotide, Vyleesi

A cyclic heptapeptide melanocortin receptor agonist studied for its influence on sexual arousal and libido in both male and female research models. Acts centrally through melanocortin receptors in the brain. FDA-approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women.

Back to Peptide Encyclopedia